180 related articles for article (PubMed ID: 36935372)
1. Resistance to antibacterial antifolates in multidrug-resistant Staphylococcus aureus: prevalence estimates and genetic basis.
Kime L; Waring T; Mohamad M; Mann BF; O'Neill AJ
J Antimicrob Chemother; 2023 May; 78(5):1201-1210. PubMed ID: 36935372
[TBL] [Abstract][Full Text] [Related]
2. Toward Broad Spectrum Dihydrofolate Reductase Inhibitors Targeting Trimethoprim Resistant Enzymes Identified in Clinical Isolates of Methicillin Resistant
Reeve SM; Si D; Krucinska J; Yan Y; Viswanathan K; Wang S; Holt GT; Frenkel MS; Ojewole AA; Estrada A; Agabiti SS; Alverson JB; Gibson ND; Priestley ND; Wiemer AJ; Donald BR; Wright DL
ACS Infect Dis; 2019 Nov; 5(11):1896-1906. PubMed ID: 31565920
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Resistance to Folate Pathway Inhibitors in
Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
[TBL] [Abstract][Full Text] [Related]
4. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.
Oefner C; Bandera M; Haldimann A; Laue H; Schulz H; Mukhija S; Parisi S; Weiss L; Lociuro S; Dale GE
J Antimicrob Chemother; 2009 Apr; 63(4):687-98. PubMed ID: 19211577
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Detection of Hemin-Inducible Trimethoprim-Sulfamethoxazole Heteroresistance in Staphylococcus aureus.
Nurjadi D; Chanthalangsy Q; Zizmann E; Stuermer V; Moll M; Klein S; Boutin S; Heeg K; Zanger P
Microbiol Spectr; 2021 Oct; 9(2):e0151021. PubMed ID: 34704796
[TBL] [Abstract][Full Text] [Related]
6. Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe.
Nurjadi D; Olalekan AO; Layer F; Shittu AO; Alabi A; Ghebremedhin B; Schaumburg F; Hofmann-Eifler J; Van Genderen PJ; Caumes E; Fleck R; Mockenhaupt FP; Herrmann M; Kern WV; Abdulla S; Grobusch MP; Kremsner PG; Wolz C; Zanger P
J Antimicrob Chemother; 2014 Sep; 69(9):2361-8. PubMed ID: 24855123
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454).
Sekiguchi J; Tharavichitkul P; Miyoshi-Akiyama T; Chupia V; Fujino T; Araake M; Irie A; Morita K; Kuratsuji T; Kirikae T
Antimicrob Agents Chemother; 2005 Sep; 49(9):3948-51. PubMed ID: 16127079
[TBL] [Abstract][Full Text] [Related]
8. Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase.
Frey KM; Lombardo MN; Wright DL; Anderson AC
J Struct Biol; 2010 Apr; 170(1):93-7. PubMed ID: 20026215
[TBL] [Abstract][Full Text] [Related]
9. Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistance.
Frey KM; Viswanathan K; Wright DL; Anderson AC
Antimicrob Agents Chemother; 2012 Jul; 56(7):3556-62. PubMed ID: 22491688
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus.
Oefner C; Parisi S; Schulz H; Lociuro S; Dale GE
Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):751-7. PubMed ID: 19622858
[TBL] [Abstract][Full Text] [Related]
11. Nonracemic Antifolates Stereoselectively Recruit Alternate Cofactors and Overcome Resistance in S. aureus.
Keshipeddy S; Reeve SM; Anderson AC; Wright DL
J Am Chem Soc; 2015 Jul; 137(28):8983-90. PubMed ID: 26098608
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Molecular Epidemiology of an Emerging Panton-Valentine Leukocidin-Positive ST5 Methicillin-Resistant Staphylococcus aureus Clone in Northern Australia.
McGuinness SL; Holt DC; Harris TM; Wright C; Baird R; Giffard PM; Bowen AC; Tong SYC
mSphere; 2021 Feb; 6(1):. PubMed ID: 33568451
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance.
Frey KM; Liu J; Lombardo MN; Bolstad DB; Wright DL; Anderson AC
J Mol Biol; 2009 Apr; 387(5):1298-308. PubMed ID: 19249312
[TBL] [Abstract][Full Text] [Related]
14. Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria.
Schneider P; Hawser S; Islam K
Bioorg Med Chem Lett; 2003 Dec; 13(23):4217-21. PubMed ID: 14623005
[TBL] [Abstract][Full Text] [Related]
15. Investigation of trimethoprim/sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting.
Harris TM; Bowen AC; Holt DC; Sarovich DS; Stevens K; Currie BJ; Howden BP; Carapetis JR; Giffard PM; Tong SYC
Clin Microbiol Infect; 2018 Sep; 24(9):1027-1029. PubMed ID: 29723570
[No Abstract] [Full Text] [Related]
16. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
17. The effects of iclaprim on exotoxin production in methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Bryant AE; Gomi S; Katahira E; Huang DB; Stevens DL
J Med Microbiol; 2019 Mar; 68(3):456-466. PubMed ID: 30676310
[TBL] [Abstract][Full Text] [Related]
18. Iclaprim activity against wild-type and corresponding thymidine kinase-deficient Staphylococcus aureus in a mouse protection model.
Huang DB; Park JH; Murphy TM
Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):409-412. PubMed ID: 30483998
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of an increase in trimethoprim/sulfamethoxazole-resistant MRSA reveals multiple introductions into a tertiary care hospital, Germany 2012-19.
Nurjadi D; Klein S; Hannesen J; Heeg K; Boutin S; Zanger P
J Antimicrob Chemother; 2021 Dec; 77(1):38-48. PubMed ID: 34529777
[TBL] [Abstract][Full Text] [Related]
20. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques.
Vickers AA; Potter NJ; Fishwick CW; Chopra I; O'Neill AJ
J Antimicrob Chemother; 2009 Jun; 63(6):1112-7. PubMed ID: 19383727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
